New calculations from Cancer Research UK estimate that, on average, over 65,000 people in England are left waiting longer than 28 days to find out whether they have cancer each month.
We’ve sent robots to mars, split the atom and mapped the human genome. Why, then, is there still so much more to understand about a disease that affects one in two of us?
To help revolutionise what cancer outcomes will look like in England in 2032, our Campaigns Ambassadors submitted evidence to inform the Government’s upcoming 10-Year Cancer Plan.
Executive Director of Research and Innovation, Iain Foulkes introduces our new innovation engine – Cancer Research Horizons
A new study has found that the level of a person’s immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer.
We invited our clinical research community to pose us questions to make sure we are doing all we can to help the recovery of cancer clinical trials to pre-pandemic levels
Results have revealed that around half of those eligible would prefer self-sampling for cervical screening over being tested by a clinician.
You may not know that as well as funding cancer research, we also work with industry and academia to develop promising ideas and turn them into real benefit for patients. Find out about Cancer Research Horizons.
Lifelong excess weight almost doubles a woman’s risk of developing womb cancer, according to a Cancer Research UK-funded study published in BMC Medicine.